Aytu Biopharma (AYTU) Times Interest Earned (2010 - 2026)
Aytu Biopharma (AYTU) reported Times Interest Earned of -$9.32 for Q1 2026, down 446.51% year-over-year from $2.69 in Q1 2025, and down 164.97% quarter-over-quarter from -$3.52 in Q4 2025.
Aytu Biopharma (AYTU) Times Interest Earned (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 15 years of Times Interest Earned data on file, last reported at -$9.32 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$9.32, down 446.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.56 (down 678.55% YoY), and the FY2025 annual result was -$0.78, down 148.77% from the prior year.
- Times Interest Earned fell to -$9.32 in Q1 2026 per AYTU's latest filing, from -$3.52 in the prior quarter.
- Over five years, Times Interest Earned peaked at $2.69 in Q1 2025 and troughed at -$9.32 in Q1 2026.
- A 4-year average of -$1.87 and a median of -$1.57 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned soared 311.73% in 2025, then tumbled 446.51% in 2026.
- A 4-year view of Times Interest Earned shows it stood at $2.48 in 2023, then tumbled by 163.22% to -$1.57 in 2024, then tumbled by 123.94% to -$3.52 in 2025, then slumped by 164.97% to -$9.32 in 2026.
- Business Quant data shows AYTU's Times Interest Earned at -$9.32 in Q1 2026, -$3.52 in Q4 2025, and -$2.91 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | -9.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.32 |
| Dec 31, 2025 | -3.52 |
| Sep 30, 2025 | -2.91 |
| Jun 30, 2025 | -3.69 |
| Mar 31, 2025 | 2.69 |
| Dec 31, 2024 | -1.57 |
| Sep 30, 2024 | -0.94 |
| Jun 30, 2024 | -1.81 |
| Mar 31, 2024 | -1.27 |
| Dec 31, 2023 | 2.48 |
| Sep 30, 2023 | -0.68 |
| Sep 30, 2020 | -4.73 |
| Jun 30, 2020 | -4.66 |
| Mar 31, 2020 | -8.90 |
| Dec 31, 2019 | -11.11 |
| Sep 30, 2019 | -24.24 |
| Jun 30, 2019 | -33.51 |
| Mar 31, 2019 | -22.08 |
| Dec 31, 2018 | -35.67 |
| Sep 30, 2018 | -44.63 |